P.B.P Enterprises Private Limited

In adults with type 2 diabetes, MOUNJARO KwikPen is used to improve blood sugar control. In adults who are overweight or have obesity, MOUNJARO is used for weight management. In adults who are obese, MOUNJARO KwikPen is also used to treat moderate to severe obstructive sleep apnoea.

The pen will be available in six dose strengths: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg, allowing healthcare professionals to personalise treatment plans. Eli Lilly and Company announced that Mounjaro KwikPen (tirzepatide) is now available across India in all doses.

Mounjaro 5mg Solution for Injection is a prescription medicine used to improve blood sugar control in adults with type 2 diabetes and support weight management in individuals who are overweight and those with obesity. It works by mimicking natural hormones to enhance insulin secretion and regulate appetite.

Mounjaro KwikPen is approved to treat adults with type 2 diabetes and for weight management in adult patients with a BMI of 30kg/m² or more (obesity), as well as those with a BMI between 27-30kg/m² (overweight) who also have weight-related health problems such as prediabetes, high blood pressure, high cholesterol. The manufacturer of the Mounjaro KwikPen, Eli Lilly, states that the device is a disposable multi-use pen that's designed for just 4 fixed doses of 0.6ml. After administering 4 doses, the pen should be safely disposed of in a sharps bin.